Aller au contenu principal
Profil bibliographique

Raymond Sawaya

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

530Publications signalées
36702Citations signalées
2Affiliations récentes

Les institutions déclarées

Les domaines associés

Glioma Diagnosis and TreatmentBrain Metastases and TreatmentMeningioma and schwannoma managementProtease and Inhibitor MechanismsRadiomics and Machine Learning in Medical Imaging

Les publications récentes

2026 article OpenAlex

Ventricular entry and postoperative leptomeningeal metastasis after resection of supratentorial high-grade glioma

Christina Abi Faraj, Ian E. McCutcheon, Ben A. Strickland, J. Matthew Debnam et autres

OBJECTIVE: Ventricular entry (VE) during resection can maximize high-grade glioma (HGG) resection, but it remains unclear whether tumor contiguity to the ventricles or VE increases the risk of leptomeningeal metastasis (LM) and/or worsens overall survival (OS). METHODS: To clarify the role of …

us, lb (code pays fourni par la source)

0 citations Journal of neurosurgery
Accès ouvert 2025 article OpenAlex

Therapy, Safety, and Logistics of Preoperative vs Postoperative Stereotactic Radiation Therapy

D.N. Yeboa, Jing Li, Ruitao Lin, Sujit S. Prabhu et autres

Importance: Preoperative stereotactic radiation therapy (SRT) vs postoperative SRT logistics and toxic effects provides clinically significant data on management outcomes. Objective: To determine preoperative SRT logistics and safety profile compared with postoperative in patients with brain metastases. Design, Setting, and Participants: This …

us, lb (code pays fourni par la source)

9 citations JAMA Oncology
Accès ouvert 2023 article OpenAlex

Multidisciplinary Care of a Large Brain Metastasis in a Patient with Hormone-Receptor-Positive Breast Cancer with Ataxia-Telangiectasia Mutation

Anca Chelariu-Raicu, Sarina A. Piha‐Paul, Mariana Chávez‐MacGregor, Jason M. Johnson et autres

ABSTRACT Poly (adenosine diphosphate-ribose) polymerase inhibitors (PARP)i are emerging as standard oncology treatments in various tumor types. The indications will expand as PARPi are being investigated in various breast cancer subtypes. Currently, except for BRCA1/2 mutation carriers with human epidermal growth factor …

us, de (code pays fourni par la source)

2 citations Journal of Immunotherapy and Precision Oncology

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.